Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2026-01-30
• Last 15 days FTD volume: A$0.58 M
• Last 3 months FTD volume: A$20.51 M
• Last 12 months FTD volume: A$0.24 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Johnson & Johnson JNJ	A$35.31 M	A$0.12 B	🇺🇸 USA
Pfizer PFE	A$61.7 M	A$0.13 B	🇺🇸 USA
AbbVie ABBV	A$0.11 B	A$0.15 B	🇺🇸 USA
Eli Lilly LLY	A$0.19 B	A$0.40 B	🇺🇸 USA
Amgen AMGN	A$0.20 B	A$0.38 B	🇺🇸 USA
Biogen BIIB	A$3.43 M	A$74.8 M	🇺🇸 USA
Illumina ILMN	A$8.54 M	A$22.72 M	🇺🇸 USA
Vertex Pharmaceuticals VRTX	A$37.87 M	A$0.10 B	🇺🇸 USA
Merck MRK	A$0.10 B	A$0.21 B	🇺🇸 USA